| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 41 |
| 1 | LORAZEPAM | 13 |
| 2 | UPADACITINIB | 13 |
| 3 | PANTOPRAZOLE | 12 |
| 4 | VENLAFAXINE HYDROCHLORIDE | 11 |
| 5 | ERGOCALCIFEROL | 10 |
| 6 | VENLAFAXINE | 10 |
| 7 | AMLODIPINE | 9 |
| 8 | ASPIRIN | 9 |
| 9 | METFORMIN | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NEDOSIRAN | 1 | 0.0833 |
| 1 | PHENAZOPYRIDINE HYDROCHLORIDE | 4 | 0.0121 |
| 2 | ACETAMINOPHEN, ASPIRIN, CAFFEINE | 2 | 0.0089 |
| 3 | POLYMYXIN B SULFATE AND TRIMETHOPRIM SULFATE | 1 | 0.0061 |
| 4 | CASTOR OIL | 1 | 0.0052 |
| 5 | HYDROCHLORIC ACID | 1 | 0.0045 |
| 6 | LUMASIRAN | 1 | 0.0026 |
| 7 | PRAMOXINE HYDROCHLORIDE HYDROCORTISONE ACETATE | 2 | 0.0025 |
| 8 | OCTOCRYLENE, AVOBENZONE | 1 | 0.0022 |
| 9 | FOSFOMYCIN TROMETHAMINE | 1 | 0.0016 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 24 |
| 1 | Benzodiazepine [EPC] | 22 |
| 2 | GLP-1 Receptor Agonist [EPC] | 20 |
| 3 | Janus Kinase Inhibitor [EPC] | 18 |
| 4 | Kinase Inhibitor [EPC] | 17 |
| 5 | Corticosteroid [EPC] | 16 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 16 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 11 |
| 8 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 11 |
| 9 | Aminosalicylate [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | Provitamin D2 Compound [EPC] | 10 | 0.0003 |
| 2 | Monoamine Oxidase Inhibitor [EPC] | 1 | 0.0003 |
| 3 | GLP-2 Analog [EPC] | 4 | 0.0003 |
| 4 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 5 | Interleukin-17A Antagonist [EPC] | 8 | 0.0002 |
| 6 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 7 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 8 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 9 | Vasopressin V2 Receptor Antagonist [EPC] | 2 | 0.0001 |